Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
10/2003
10/29/2003EP0892632B1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders
10/29/2003EP0703985B1 Recombinant stratum corneum chymotryptic enzyme (scce)
10/29/2003CN1452628A 4-halogenated 17-methylene steroids, method for production thereof and pharmaceutical compositions contg. these compounds
10/29/2003CN1452620A Imidazolo-5-yl-2-anilino-pyrimidines as agents for inhibition of cell proliferation
10/29/2003CN1452493A Method for cell adhesion and wound healing
10/29/2003CN1452492A Neuroprotective peptides
10/29/2003CN1452488A Treatment of inflammatory disorders
10/29/2003CN1452483A IL-8 receptor antagonists
10/29/2003CN1451433A Shenji ointment and preparing process thereof
10/29/2003CN1451415A Medicine for treating acne and preparing process thereof
10/29/2003CN1451414A Spot eliminating medicine and preparing process thereof
10/29/2003CN1451405A Chinese medicine plaster for treating psoriasis
10/29/2003CN1451403A Beauty and health oral liquid and preparing process thereof
10/29/2003CN1451391A Medicine for treating dermatopathy
10/29/2003CN1451390A Medicine use of cyclodextrin derivs. and medicine composition thereof
10/29/2003CN1451389A Agent for promoting cell activation for external use
10/29/2003CN1125651C Novel synergistic compositions containing aromatic compounds and terpenoids present in alpinia galanga
10/29/2003CN1125645C Ointment for treating psoriasis
10/29/2003CN1125644C Ointment for treating acne
10/29/2003CN1125643C External use medicine for treating psoriasis
10/28/2003US6639051 Regulation of epithelial tissue by hedgehog-like polypeptides, and formulations and uses related thereto
10/28/2003US6638957 Inhibition of 1-deoxy-D-xylulose-5-phosphate metabolic pathway
10/28/2003US6638950 Piperidine amides as modulators of chemokine receptor activity
10/28/2003US6638949 Angiogenesis inhibitor is selective, such as a fumagillol derivative like 0-chloroacetylcarbamoyl-Fumagillol, thalidomide, or a selective drug having more than one activity, such as minocycline or penicilliamine which also
10/28/2003US6638944 Have urea containing substituent at 1-position; induce biosynthesis of cytokines such as interferon and tumor necrosis factor, exhibit antiviral and antitumor properties
10/28/2003US6638926 Pyrazole compounds useful as protein kinase inhibitors
10/28/2003US6638922 4-dedimethylaminotetracycline derivatives
10/28/2003US6638918 Chitosan compositions
10/28/2003US6638740 Chromatography, elution, ion exchanging
10/28/2003US6638543 Comprising an admixture of a natural inhibitor of epidermal growth factor receptor (EGFR) activation or a derivative or analog and a dermatological carrier; antipeeling agents; genistein and other isoflavones and other plant extracts
10/28/2003CA2253796C Inhibition of matrix metalloproteases by acetylene containing compounds
10/28/2003CA2252701C Halo-substituted protein kinase c inhibitors
10/23/2003WO2003087411A1 Method to inhibit cell growth using oligonucleotides
10/23/2003WO2003087362A1 Novel g protein-coupled receptor gene and protein bg8
10/23/2003WO2003087345A2 Stimulation of nerve cell regeneration
10/23/2003WO2003087318A2 Truncated 24 kda basic fibroblast growth factor
10/23/2003WO2003087304A2 Tri-substituted heteroaryls and methods of making and using the same
10/23/2003WO2003087296A2 Novel methods for the in-vitro identification, isolation and differentiation of vasculogenic progenitor cells
10/23/2003WO2003087220A2 Solid emulsions based on thermoplastic elastomers
10/23/2003WO2003087174A2 Carbocyclic and oxacarbocyclic fumaric acid oligomers
10/23/2003WO2003087160A1 Modification of the properties of a fibrin matrix with respect to growth and ingrowth of cells
10/23/2003WO2003087090A2 Novel heteroaryl alkylamide derivatives useful as bradykinin receptor modulators
10/23/2003WO2003087089A1 Piperidine derivatives having ccr3 antagonism
10/23/2003WO2003087087A2 Heterocyclic compounds and their use as modulators of p38 map kinase
10/23/2003WO2003087062A2 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
10/23/2003WO2003087061A1 Pyrazole compounds as anti-inflammatory and analgesic agents
10/23/2003WO2003086472A1 Drugs to be used in gene therapy for recessively transmitted genetic disease
10/23/2003WO2003086463A1 Remedies for pemphigus containing cd40l antagonist as the active ingredient
10/23/2003WO2003086460A2 High fluence rate activation of photosensitizers for dermatological applications
10/23/2003WO2003086458A1 Recombinant anti-interleukin-9 antibodies
10/23/2003WO2003086435A1 Cleanser
10/23/2003WO2003086434A1 Drinking tea for treating dermatitis
10/23/2003WO2003086433A1 Therapeutic cream for dermatitis
10/23/2003WO2003086432A1 Therapeutic lotion for dermatitis
10/23/2003WO2003086425A1 An anti-rheumatism medicament and method to prepare thereof
10/23/2003WO2003086421A1 External preparations for enhancing cell activity
10/23/2003WO2003086420A1 Use of acarbose and the derivatives thereof for the treatment and prophylaxis of degenerative skin conditions
10/23/2003WO2003086419A1 Antibiotic/benzoyl peroxide dispenser
10/23/2003WO2003086413A1 Pharmaceutical compositions containing water-soluble prodrugs of propofol and methods of administering same
10/23/2003WO2003086400A1 N-substituted pyridinone and pyrimidinone derivatives for use as lp-pla2 inhibitors in the treatment of artherosclerosis
10/23/2003WO2003086396A1 Phosphodiesterase iv inhibitor containing pyridylacrylamide derivative
10/23/2003WO2003086389A1 Use of a photosensitising compound for the preparation of a pharmaceutical composition for treating of burns, and a method of treating burns
10/23/2003WO2003086384A1 Stabilized ascorbic acid derivatives
10/23/2003WO2003086373A1 Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
10/23/2003WO2003086354A1 Nanoparticulate megestrol formulations
10/23/2003WO2003086351A1 Compositions and methods for dosing liposomes of certain sizes to treat or prevent disease
10/23/2003WO2003086348A1 Allergic dermatitis formulation and method of treatment
10/23/2003WO2003086341A2 Aminophenylbenzothiazole compounds
10/23/2003WO2003086334A1 Hair growth tonic
10/23/2003WO2003086329A2 Skincare compositions comprising anti-oxidant agents
10/23/2003WO2003086326A2 G-type peptides to ameliorate atherosclerosis
10/23/2003WO2003086324A2 Preparation and use of a stable formulation of allosteric effector compounds
10/23/2003WO2003086317A2 Protein a compositions and methods of use
10/23/2003WO2003086315A2 Tyrosine kinase inhibitors
10/23/2003WO2003086314A2 Tyrosine kinase inhibitors
10/23/2003WO2003086311A2 Methods for treating tweak-related conditions
10/23/2003WO2003086309A2 NF-κB INHIBITORS
10/23/2003WO2003086294A2 1h-benzo[f]indazol-5-yl derivatives as selective glucocorticoid receptor modulators
10/23/2003WO2003086282A2 Nitric oxide donors, compositions and methods of use
10/23/2003WO2003057252A8 Human mast cell-expressed membrane proteins
10/23/2003WO2003057147A3 Useful aroyl pyrrole heteroaryl methanones and methanols
10/23/2003WO2003039473A3 Method for treating or preventing inflammatory diseases
10/23/2003WO2003022255A3 Lactic acid bacteria comprising unmethylated cytosine-guanine dinucleotides for use in therapy
10/23/2003WO2003017824A3 Method and apparatus for acne treatment
10/23/2003WO2003007954A3 Sulfonyl aryl hydroxamates and their use as matrix metalloprotease inhibitors
10/23/2003WO2002092029A3 Cosmetic and dermatological preparations for removing and regulating sebum
10/23/2003WO2002092015A3 Reagents and methods for modulating dkk-mediated interactions
10/23/2003WO2002081521A8 Osteoprotegerin in milk
10/23/2003WO2002079456A3 A method for the preparation of immunologically inert amniotic membranes
10/23/2003WO2002077216A3 Ikk2 variant, dino gene, lectin-like receptor gene, and proteins encoded thereby
10/23/2003WO2002077199A3 Methods and products related to fgf dimerization
10/23/2003WO2002066494A8 Identification and cloning of a novel human gene, ret16, involved in the intracellular signaling cascade
10/23/2003WO2002046384A3 Kinases and phosphatases sequences, and use thereof
10/23/2003WO2001009328A8 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof
10/23/2003WO2001002567A8 16405 receptor, a g-protein coupled receptor
10/23/2003US20030199701 Treating under hydrolyzing conditions a hydantoin compound to form an alpha-amino acid derivative
10/23/2003US20030199679 Recombinant antibodies specific for TNF-alpha
10/23/2003US20030199569 Pyrrolidine derivatives
10/23/2003US20030199567 Combinations of an alpha-2-delta ligand with a selective inhibitor of cyclooxygenase-2
10/23/2003US20030199562 Substituted benzoxazoles as estrogenic agents
1 ... 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 ... 1065